Verdinexor, the specific inhibitor of XPO1, suppressed the neuroblastoma cell growth and induced cell apoptosis by FOXO1 and RB1 nuclear accumulation through inhibition of the PI3K/AKT pathway. This evidence concerns the gene FOXO1 and neuroblastoma.